» Articles » PMID: 30520008

Examining HPV Vaccination Practices and Differences Among Providers in Virginia

Overview
Journal J Cancer Educ
Publisher Springer
Date 2018 Dec 7
PMID 30520008
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Virginia has some of the lowest HPV vaccination rates, despite being one of the few states in the USA requiring adolescent girls receive the vaccine. Provider characteristics may be an important factor in HPV vaccination. Thus, the present study assessed provider vaccination, practices, knowledge about the vaccine, and confidence in performing behaviors related to the vaccine. We conducted a cross-sectional electronic survey in a large health care system in Northern Virginia. A total of 53 responses were received. Only respondents who reported seeing adolescent patients were included in analyses (N = 42). Differences in responses were examined by provider age, gender, and type. Respondents reported recommending the vaccine a high percent of the time to eligible patients and had overall high levels of knowledge and confidence. Male providers recommended the vaccine to boys ages 11-12, less frequently than female providers. Providers age 50 and over recommended the vaccine to boys ages 11-12 less frequently than younger providers. This study shows that there are some gaps in HPV vaccine recommendation practices among providers. These gaps may be one reason for the low uptake of the HPV vaccine among adolescents. Thus, educational and training interventions of providers could be considered.

Citing Articles

Identifying Healthcare Professionals With Lower Human Papillomavirus (HPV) Vaccine Recommendation Quality: A Systematic Review.

Kong W, Oh N, Kennedy K, Carlson R, Liu A, Ozawa S J Adolesc Health. 2024; 74(5):868-877.

PMID: 38231146 PMC: 11031337. DOI: 10.1016/j.jadohealth.2023.11.016.


Disparities in Healthcare Providers' Recommendation of HPV Vaccination for U.S. Adolescents: A Systematic Review.

Kong W, Bustamante G, Pallotto I, Margolis M, Carlson R, McRee A Cancer Epidemiol Biomarkers Prev. 2021; 30(11):1981-1992.

PMID: 34426414 PMC: 8568647. DOI: 10.1158/1055-9965.EPI-21-0733.


The perspectives, barriers, and willingness of Utah dentists to engage in human papillomavirus (HPV) vaccine practices.

Harris K, Tay D, Kaiser D, Praag A, Rutkoski H, Dixon B Hum Vaccin Immunother. 2019; 16(2):436-444.

PMID: 31361179 PMC: 7062442. DOI: 10.1080/21645515.2019.1649550.

References
1.
Collange F, Fressard L, Pulcini C, Sebbah R, Peretti-Watel P, Verger P . General practitioners' attitudes and behaviors toward HPV vaccination: A French national survey. Vaccine. 2016; 34(6):762-8. DOI: 10.1016/j.vaccine.2015.12.054. View

2.
Javanbakht M, Stahlman S, Walker S, Gottlieb S, Markowitz L, Liddon N . Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community. Vaccine. 2012; 30(30):4511-6. DOI: 10.1016/j.vaccine.2012.04.062. View

3.
Verger P, Fressard L, Collange F, Gautier A, Jestin C, Launay O . Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France. EBioMedicine. 2015; 2(8):891-7. PMC: 4563133. DOI: 10.1016/j.ebiom.2015.06.018. View

4.
McLean H, VanWormer J, Chow B, Birchmeier B, Vickers E, DeVries E . Improving Human Papillomavirus Vaccine Use in an Integrated Health System: Impact of a Provider and Staff Intervention. J Adolesc Health. 2017; 61(2):252-258. PMC: 6749828. DOI: 10.1016/j.jadohealth.2017.02.019. View

5.
Gilkey M, Malo T, Shah P, Hall M, Brewer N . Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiol Biomarkers Prev. 2015; 24(11):1673-9. PMC: 4633386. DOI: 10.1158/1055-9965.EPI-15-0326. View